Highlights
1 patent
About
Intrauterine Treatment for Improving Embryo Implantation Rates
NanoCell is dedicated to advancing womens reproductive health through biopharmaceutical technologies. The companys proprietary intrauterine treatment significantly improves embryo implantation, thereby increasing the chances of conception. NanoCell is developing a method, kit, and composition for increasing the implantation rate of embryos in both humans and livestock using enzymatically remodeled extra-cellular matrix (ECM) to improve the efficiency of embryo implantation.
Identity
| Name | NanoCell |
|---|---|
| Slug | nanocell |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Or4rMgKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Aug 2024 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rehovot |
| HQ address | Rehovot, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & SubstancesImplantsComposites
Target customers
Healthcare & Life SciencesHealthcareProvidersConsumersDemographics & FamilyWomenAgriculture & FoodLivestock
Business models
B2B
Tags
femtechcomposite-materialswomen-healthmedical-devicesfertilitywomenpregnancymedical-technologiesbiopharmaceuticallivestock
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}